1. Home
  2. GPUS vs RDHL Comparison

GPUS vs RDHL Comparison

Compare GPUS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • RDHL
  • Stock Information
  • Founded
  • GPUS 1969
  • RDHL 2009
  • Country
  • GPUS United States
  • RDHL Israel
  • Employees
  • GPUS N/A
  • RDHL N/A
  • Industry
  • GPUS
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • RDHL Health Care
  • Exchange
  • GPUS NYSE
  • RDHL Nasdaq
  • Market Cap
  • GPUS 4.1M
  • RDHL 8.2M
  • IPO Year
  • GPUS 1996
  • RDHL N/A
  • Fundamental
  • Price
  • GPUS $3.87
  • RDHL $5.85
  • Analyst Decision
  • GPUS
  • RDHL
  • Analyst Count
  • GPUS 0
  • RDHL 0
  • Target Price
  • GPUS N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • GPUS 60.6K
  • RDHL 11.1K
  • Earning Date
  • GPUS 11-19-2024
  • RDHL 08-29-2024
  • Dividend Yield
  • GPUS N/A
  • RDHL N/A
  • EPS Growth
  • GPUS N/A
  • RDHL N/A
  • EPS
  • GPUS N/A
  • RDHL N/A
  • Revenue
  • GPUS $139,425,000.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • GPUS N/A
  • RDHL $224.90
  • Revenue Next Year
  • GPUS N/A
  • RDHL $82.69
  • P/E Ratio
  • GPUS N/A
  • RDHL N/A
  • Revenue Growth
  • GPUS 3.50
  • RDHL N/A
  • 52 Week Low
  • GPUS $3.09
  • RDHL $5.41
  • 52 Week High
  • GPUS $35.89
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • RDHL 40.41
  • Support Level
  • GPUS N/A
  • RDHL $5.80
  • Resistance Level
  • GPUS N/A
  • RDHL $6.26
  • Average True Range (ATR)
  • GPUS 0.00
  • RDHL 0.31
  • MACD
  • GPUS 0.00
  • RDHL 0.01
  • Stochastic Oscillator
  • GPUS 0.00
  • RDHL 19.33

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: